JRJ
STML

Jeffrey R. Jay’s Stemline Therapeutics, Inc. STML Stock Holding History

Jeffrey R. Jay’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$14.2M Buy
+595,493
New +$9.48M 11.22% 3

Other funds holding STML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Jeffrey R. Jay's STML Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Stemline Therapeutics, Inc. (STML) in Q2 2013: 595,493 shares worth $14.2M. The stake represents 11.22% of the portfolio and ranks #3 among its holdings.

56 funds tracked by Wall St. Rank hold STML as of Q2 2013.

  • Jeffrey R. Jay held 595,493 shares of Stemline Therapeutics, Inc. worth $14.2M as of Q2 2013.
  • Stemline Therapeutics, Inc. was a new Jeffrey R. Jay position in Q2 2013.
  • Stemline Therapeutics, Inc. made up 11.22% of Jeffrey R. Jay's portfolio in Q2 2013, its #3 holding.
  • 56 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.